nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0757	0.268	CbGeAlD
Nabumetone—CYP1A2—urine—polycystic ovary syndrome	0.0382	0.136	CbGeAlD
Nabumetone—Agomelatine—MTNR1B—polycystic ovary syndrome	0.0329	0.426	CrCbGaD
Nabumetone—Melatonin—MTNR1B—polycystic ovary syndrome	0.0193	0.25	CrCbGaD
Nabumetone—Naproxen—AKR1C3—polycystic ovary syndrome	0.0159	0.207	CrCbGaD
Nabumetone—MPO—pituitary gland—polycystic ovary syndrome	0.0149	0.053	CbGeAlD
Nabumetone—MPO—adrenal gland—polycystic ovary syndrome	0.0134	0.0473	CbGeAlD
Nabumetone—MPO—endocrine gland—polycystic ovary syndrome	0.0116	0.0411	CbGeAlD
Nabumetone—Azotaemia—Metformin—polycystic ovary syndrome	0.0103	0.121	CcSEcCtD
Nabumetone—PTGS2—embryo—polycystic ovary syndrome	0.0102	0.0363	CbGeAlD
Nabumetone—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00839	0.0297	CbGeAlD
Nabumetone—PTGS1—endometrium—polycystic ovary syndrome	0.00783	0.0278	CbGeAlD
Nabumetone—PTGS2—endometrium—polycystic ovary syndrome	0.00749	0.0266	CbGeAlD
Nabumetone—PTGS1—uterus—polycystic ovary syndrome	0.00722	0.0256	CbGeAlD
Nabumetone—PTGS1—pituitary gland—polycystic ovary syndrome	0.00709	0.0251	CbGeAlD
Nabumetone—PTGS1—adipose tissue—polycystic ovary syndrome	0.00706	0.025	CbGeAlD
Nabumetone—PTGS2—uterus—polycystic ovary syndrome	0.0069	0.0245	CbGeAlD
Nabumetone—PTGS2—pituitary gland—polycystic ovary syndrome	0.00678	0.024	CbGeAlD
Nabumetone—PTGS2—adipose tissue—polycystic ovary syndrome	0.00675	0.0239	CbGeAlD
Nabumetone—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00634	0.0225	CbGeAlD
Nabumetone—PTGS1—adrenal gland—polycystic ovary syndrome	0.00633	0.0225	CbGeAlD
Nabumetone—PTGS2—adrenal gland—polycystic ovary syndrome	0.00605	0.0215	CbGeAlD
Nabumetone—PTGS1—female gonad—polycystic ovary syndrome	0.00591	0.0209	CbGeAlD
Nabumetone—PTGS1—vagina—polycystic ovary syndrome	0.00587	0.0208	CbGeAlD
Nabumetone—PTGS2—female gonad—polycystic ovary syndrome	0.00564	0.02	CbGeAlD
Nabumetone—PTGS2—vagina—polycystic ovary syndrome	0.00561	0.0199	CbGeAlD
Nabumetone—PTGS1—endocrine gland—polycystic ovary syndrome	0.00549	0.0195	CbGeAlD
Nabumetone—PTGS2—endocrine gland—polycystic ovary syndrome	0.00525	0.0186	CbGeAlD
Nabumetone—Melatonin—CYP19A1—polycystic ovary syndrome	0.00523	0.0678	CrCbGaD
Nabumetone—Melatonin—CYP1A1—polycystic ovary syndrome	0.00385	0.0499	CrCbGaD
Nabumetone—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00368	0.043	CcSEcCtD
Nabumetone—Pancreatitis—Metformin—polycystic ovary syndrome	0.00338	0.0395	CcSEcCtD
Nabumetone—Sweating increased—Metformin—polycystic ovary syndrome	0.00336	0.0393	CcSEcCtD
Nabumetone—Angina pectoris—Metformin—polycystic ovary syndrome	0.00336	0.0393	CcSEcCtD
Nabumetone—Chills—Metformin—polycystic ovary syndrome	0.00247	0.0289	CcSEcCtD
Nabumetone—Flatulence—Metformin—polycystic ovary syndrome	0.00237	0.0277	CcSEcCtD
Nabumetone—Tremor—Metformin—polycystic ovary syndrome	0.00225	0.0263	CcSEcCtD
Nabumetone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00223	0.0261	CcSEcCtD
Nabumetone—Malaise—Metformin—polycystic ovary syndrome	0.00217	0.0253	CcSEcCtD
Nabumetone—Syncope—Metformin—polycystic ovary syndrome	0.00215	0.0252	CcSEcCtD
Nabumetone—Palpitations—Metformin—polycystic ovary syndrome	0.00212	0.0248	CcSEcCtD
Nabumetone—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00211	0.0247	CcSEcCtD
Nabumetone—Hypertension—Metformin—polycystic ovary syndrome	0.00207	0.0242	CcSEcCtD
Nabumetone—Discomfort—Metformin—polycystic ovary syndrome	0.00202	0.0236	CcSEcCtD
Nabumetone—Oedema—Metformin—polycystic ovary syndrome	0.00196	0.0229	CcSEcCtD
Nabumetone—Shock—Metformin—polycystic ovary syndrome	0.00193	0.0225	CcSEcCtD
Nabumetone—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00192	0.0224	CcSEcCtD
Nabumetone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00189	0.0222	CcSEcCtD
Nabumetone—Anorexia—Metformin—polycystic ovary syndrome	0.00187	0.0218	CcSEcCtD
Nabumetone—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00185	0.00333	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00184	0.00332	CbGpPWpGaD
Nabumetone—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00183	0.00329	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00177	0.00318	CbGpPWpGaD
Nabumetone—Paraesthesia—Metformin—polycystic ovary syndrome	0.00176	0.0206	CcSEcCtD
Nabumetone—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00175	0.00315	CbGpPWpGaD
Nabumetone—Dyspnoea—Metformin—polycystic ovary syndrome	0.00175	0.0204	CcSEcCtD
Nabumetone—Somnolence—Metformin—polycystic ovary syndrome	0.00174	0.0204	CcSEcCtD
Nabumetone—Dyspepsia—Metformin—polycystic ovary syndrome	0.00172	0.0202	CcSEcCtD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00172	0.0031	CbGpPWpGaD
Nabumetone—Decreased appetite—Metformin—polycystic ovary syndrome	0.0017	0.0199	CcSEcCtD
Nabumetone—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.0017	0.00306	CbGpPWpGaD
Nabumetone—Fatigue—Metformin—polycystic ovary syndrome	0.00169	0.0198	CcSEcCtD
Nabumetone—Constipation—Metformin—polycystic ovary syndrome	0.00168	0.0196	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IL6—polycystic ovary syndrome	0.00167	0.003	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00165	0.00297	CbGpPWpGaD
Nabumetone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00161	0.0189	CcSEcCtD
Nabumetone—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00161	0.0029	CbGpPWpGaD
Nabumetone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0016	0.0187	CcSEcCtD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.0016	0.00288	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.0016	0.00288	CbGpPWpGaD
Nabumetone—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00158	0.00284	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00158	0.00284	CbGpPWpGaD
Nabumetone—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00157	0.00282	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00156	0.00281	CbGpPWpGaD
Nabumetone—Urticaria—Metformin—polycystic ovary syndrome	0.00156	0.0182	CcSEcCtD
Nabumetone—Abdominal pain—Metformin—polycystic ovary syndrome	0.00155	0.0181	CcSEcCtD
Nabumetone—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00153	0.00276	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00148	0.00267	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00147	0.00264	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00145	0.00262	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.00143	0.00258	CbGpPWpGaD
Nabumetone—Asthenia—Metformin—polycystic ovary syndrome	0.00141	0.0164	CcSEcCtD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.0014	0.00253	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.0014	0.00252	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.0014	0.00252	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0014	0.00251	CbGpPWpGaD
Nabumetone—Pruritus—Metformin—polycystic ovary syndrome	0.00139	0.0162	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00137	0.00247	CbGpPWpGaD
Nabumetone—Diarrhoea—Metformin—polycystic ovary syndrome	0.00134	0.0157	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00133	0.0024	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00132	0.00238	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.0013	0.00234	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.0013	0.00234	CbGpPWpGaD
Nabumetone—Dizziness—Metformin—polycystic ovary syndrome	0.0013	0.0152	CcSEcCtD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00127	0.00228	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00126	0.00227	CbGpPWpGaD
Nabumetone—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00126	0.00227	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.00126	0.00227	CbGpPWpGaD
Nabumetone—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00125	0.00225	CbGpPWpGaD
Nabumetone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.00125	0.00225	CbGpPWpGaD
Nabumetone—Vomiting—Metformin—polycystic ovary syndrome	0.00125	0.0146	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00124	0.00223	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00124	0.00223	CbGpPWpGaD
Nabumetone—Rash—Metformin—polycystic ovary syndrome	0.00124	0.0144	CcSEcCtD
Nabumetone—Dermatitis—Metformin—polycystic ovary syndrome	0.00123	0.0144	CcSEcCtD
Nabumetone—Headache—Metformin—polycystic ovary syndrome	0.00123	0.0144	CcSEcCtD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00122	0.00219	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00121	0.00219	CbGpPWpGaD
Nabumetone—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00118	0.00213	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00118	0.00212	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00117	0.00211	CbGpPWpGaD
Nabumetone—Nausea—Metformin—polycystic ovary syndrome	0.00116	0.0136	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00114	0.00205	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00111	0.002	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00111	0.002	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00111	0.002	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00111	0.002	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00106	0.00191	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00105	0.00188	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00103	0.00185	CbGpPWpGaD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00102	0.00184	CbGpPWpGaD
Nabumetone—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00101	0.00181	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000985	0.00177	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000979	0.00176	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00093	0.00167	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000911	0.00164	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000904	0.00163	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.0009	0.00162	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000897	0.00161	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000881	0.00159	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000863	0.00155	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000862	0.00155	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000861	0.00155	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000841	0.00151	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000837	0.00151	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000828	0.00149	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000825	0.00149	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000821	0.00148	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000816	0.00147	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000803	0.00145	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000794	0.00143	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.000787	0.00142	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000787	0.00142	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000777	0.0014	CbGpPWpGaD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000761	0.00137	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000741	0.00133	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000734	0.00132	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000732	0.00132	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000731	0.00132	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.00073	0.00131	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000715	0.00129	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000715	0.00129	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00069	0.00124	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000689	0.00124	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000683	0.00123	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00068	0.00122	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000668	0.0012	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000652	0.00117	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000637	0.00115	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000634	0.00114	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000628	0.00113	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000628	0.00113	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000625	0.00113	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000625	0.00113	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000622	0.00112	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000622	0.00112	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000617	0.00111	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000617	0.00111	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000598	0.00108	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000591	0.00107	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000589	0.00106	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000581	0.00105	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000568	0.00102	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000545	0.000982	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000542	0.000976	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000538	0.000969	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00053	0.000955	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000526	0.000947	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000522	0.000939	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000512	0.000923	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000503	0.000906	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000499	0.000898	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000494	0.00089	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000494	0.00089	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000494	0.00089	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000476	0.000857	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000475	0.000855	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000472	0.000849	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000468	0.000842	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000466	0.000839	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000447	0.000805	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00044	0.000792	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000434	0.000781	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00043	0.000775	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.00042	0.000757	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.00042	0.000757	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000414	0.000745	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000405	0.000728	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000401	0.000722	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000398	0.000718	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000396	0.000714	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000392	0.000707	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000387	0.000696	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000376	0.000677	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000374	0.000674	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00037	0.000666	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000369	0.000664	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000366	0.000659	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000361	0.000649	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000357	0.000644	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000354	0.000637	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000354	0.000637	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000349	0.000629	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000346	0.000623	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.00034	0.000613	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000335	0.000603	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000334	0.000601	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000329	0.000592	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000328	0.000591	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000328	0.00059	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000321	0.000579	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000319	0.000574	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000318	0.000573	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000315	0.000567	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000309	0.000556	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000305	0.000548	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000302	0.000544	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.0003	0.00054	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000298	0.000537	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000297	0.000536	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.00029	0.000523	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000286	0.000515	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000285	0.000513	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000284	0.000512	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000284	0.000511	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000282	0.000508	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00028	0.000505	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.00028	0.000503	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.00028	0.000503	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000278	0.000501	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000275	0.000495	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000271	0.000488	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000269	0.000484	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000266	0.00048	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000265	0.000477	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000262	0.000472	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000253	0.000455	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000253	0.000455	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000249	0.000448	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000245	0.000441	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000236	0.000425	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000234	0.000422	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000227	0.000409	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000227	0.000408	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000226	0.000406	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000224	0.000403	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000222	0.000401	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000222	0.0004	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000221	0.000398	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000213	0.000383	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000212	0.000382	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000212	0.000381	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000209	0.000377	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000209	0.000377	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000208	0.000375	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000208	0.000374	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRL—polycystic ovary syndrome	0.0002	0.00036	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000189	0.00034	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000185	0.000334	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.00018	0.000324	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.00018	0.000324	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000178	0.000321	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000177	0.000318	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000175	0.000316	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000169	0.000304	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000167	0.000301	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.000167	0.000301	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000165	0.000297	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000164	0.000296	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000164	0.000296	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000161	0.000289	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000156	0.000281	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000156	0.00028	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000148	0.000266	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000147	0.000265	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000143	0.000258	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IRS2—polycystic ovary syndrome	0.000141	0.000253	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	0.00014	0.000252	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000139	0.00025	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000134	0.000241	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000133	0.000239	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000128	0.000231	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000128	0.00023	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000127	0.000228	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	0.000127	0.000228	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000126	0.000227	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—POMC—polycystic ovary syndrome	0.000125	0.000225	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—INS—polycystic ovary syndrome	0.000124	0.000223	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	0.000124	0.000223	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IRS1—polycystic ovary syndrome	0.000123	0.000221	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.00012	0.000216	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000118	0.000212	CbGpPWpGaD
Nabumetone—PTGS2—Disease—INS—polycystic ovary syndrome	0.000118	0.000212	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT2—polycystic ovary syndrome	0.000114	0.000205	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	0.000108	0.000195	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TH—polycystic ovary syndrome	0.000102	0.000184	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	0.0001	0.000181	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	9.92e-05	0.000179	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—POMC—polycystic ovary syndrome	9.91e-05	0.000178	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—INS—polycystic ovary syndrome	9.85e-05	0.000177	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	9.33e-05	0.000168	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	8.32e-05	0.00015	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	7.93e-05	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.52e-05	0.000135	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	7.01e-05	0.000126	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	5.68e-05	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	5.61e-05	0.000101	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—INS—polycystic ovary syndrome	5.57e-05	0.0001	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—polycystic ovary syndrome	5.14e-05	9.25e-05	CbGpPWpGaD
